| |
| |
|
| Insider
Information: |
Huizenga Theodore Alan |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
41,366 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,791,148 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,366 |
|
|
| Total
Value |
$1,791,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -268.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-04-16 |
41,366 |
2015-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-04-16 |
4 |
D |
$42.31 |
$592 |
D/D |
(14) |
41,366 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
S |
$53.76 |
$18,332 |
D/D |
(341) |
41,380 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
D |
$53.69 |
$6,496 |
D/D |
(121) |
41,721 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,950 |
41,842 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2024-01-02 |
4 |
OE |
$21.00 |
$63,000 |
D/D |
3,000 |
27,892 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
24,614 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-09-07 |
4 |
AS |
$38.34 |
$88,249 |
D/D |
(2,163) |
23,614 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-09-07 |
4 |
OE |
$21.00 |
$42,000 |
D/D |
2,000 |
25,777 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-09-01 |
4 |
AS |
$37.04 |
$36,032 |
D/D |
(970) |
23,777 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-05-09 |
4 |
OE |
$21.00 |
$63,000 |
D/D |
3,000 |
30,747 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-04-16 |
4 |
D |
$38.20 |
$535 |
D/D |
(14) |
27,701 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-04-16 |
4 |
D |
$38.20 |
$6,914 |
D/D |
(181) |
27,520 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-03-01 |
4 |
D |
$45.65 |
$60,851 |
D/D |
(1,333) |
21,715 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-03-01 |
4 |
S |
$45.65 |
$4,565 |
D/D |
(100) |
23,048 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,590 |
23,148 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2023-02-28 |
4 |
AS |
$43.40 |
$27,733 |
D/D |
(639) |
15,558 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-12-21 |
4 |
AS |
$43.96 |
$89,283 |
D/D |
(2,031) |
16,197 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
18,094 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-04-16 |
4 |
S |
$84.55 |
$11,161 |
D/D |
(132) |
16,914 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-03-01 |
4 |
S |
$66.62 |
$56,161 |
D/D |
(843) |
13,229 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,710 |
17,046 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$11,360 |
D/D |
(140) |
14,072 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
819 |
14,212 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-05-06 |
4 |
S |
$113.67 |
$16,141 |
D/D |
(142) |
15,031 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
SVP, Chief Accounting Officer |
• – – |
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
15,044 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
